SINGAPORE, iNews.id – Singapore researchers found the Covid-19 vaccine production Pfizer-BioNTech can help the body produce antibody and immune cells within 12 days of getting the first dose.
Previously, the results of a study in Israel of medical personnel revealed that the first dose of the Pfizer-BioNTech vaccine was 85 percent effective against Covid-19.
Canadian researchers also suggested delaying the second dose of Pfizer vaccine after the results revealed 92.6 percent effectiveness in users after receiving the first dose.
Not enough, clinical data from the international Pfizer-BioNTech trial conducted on 44,000 volunteers showed that the number of Covid-19 cases among the vaccinated group decreased 10 to 12 days after they received the first dose, while cases continued to increase among the placebo group or not. get the vaccine.
The findings from international trials indicate that the Pfizer vaccine has an efficacy rate of 95 percent for the administration of two doses within 3 weeks.
Singapore researchers, namely from the Singapore General Hospital (SGH) and Duke-NUS Medical School, found efficacy within 12 days of users receiving the first dose.
This protection is the result of the early development of antibodies and a type of immune cell known as T-cells that specifically targets the SARS-CoV-2 virus that causes Covid-19.
Editor: Anton Suhartono
